214 related articles for article (PubMed ID: 23149913)
1. Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.
Stanton MJ; Dutta S; Zhang H; Polavaram NS; Leontovich AA; Hönscheid P; Sinicrope FA; Tindall DJ; Muders MH; Datta K
Cancer Res; 2013 Jan; 73(1):160-71. PubMed ID: 23149913
[TBL] [Abstract][Full Text] [Related]
2. Roles for VEGF-C/NRP-2 axis in regulating renal tubular epithelial cell survival and autophagy during serum deprivation.
Chang X; Yang Q; Zhang C; Zhang Y; Liang X; Liu Y; Xu G
Cell Biochem Funct; 2019 Jun; 37(4):290-300. PubMed ID: 31211440
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic growth factor axis in autophagy regulation.
Stanton MJ; Dutta S; Polavaram NS; Roy S; Muders MH; Datta K
Autophagy; 2013 May; 9(5):789-90. PubMed ID: 23388383
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A induces autophagy in cardiac fibroblasts through the NRP-2/WDFY-1 axis.
Chi J; Wang L; Zhang X; Fu Y; Liu Y; Chen W; Liu W; Shi Z; Yin X
Biochimie; 2018 May; 148():55-62. PubMed ID: 29501733
[TBL] [Abstract][Full Text] [Related]
5. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.
Timoshenko AV; Rastogi S; Lala PK
Br J Cancer; 2007 Oct; 97(8):1090-8. PubMed ID: 17912247
[TBL] [Abstract][Full Text] [Related]
6. NRP-2 in tumor lymphangiogenesis and lymphatic metastasis.
Wang J; Huang Y; Zhang J; Xing B; Xuan W; Wang H; Huang H; Yang J; Tang J
Cancer Lett; 2018 Apr; 418():176-184. PubMed ID: 29339213
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.
Muders MH; Zhang H; Wang E; Tindall DJ; Datta K
Cancer Res; 2009 Aug; 69(15):6042-8. PubMed ID: 19638584
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Corominas-Faja B; Urruticoechea A; Martin-Castillo B; Menendez JA
Oncotarget; 2012 Dec; 3(12):1600-14. PubMed ID: 23307622
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.
Bollard J; Patte C; Radkova K; Massoma P; Chardon L; Valantin J; Gadot N; Goddard I; Vercherat C; Hervieu V; Gouysse G; Poncet G; Scoazec JY; Walter T; Roche C
J Pathol; 2019 Nov; 249(3):343-355. PubMed ID: 31257576
[TBL] [Abstract][Full Text] [Related]
12. [The effect of on VEGF-C cDNA transfection on NB4 cell proliferation, differentiation and resistance to apoptosis].
Ding KY; Bai X; Dai L; Dong NZ; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):244-8. PubMed ID: 16875555
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines.
Samuel S; Gaur P; Fan F; Xia L; Gray MJ; Dallas NA; Bose D; Rodriguez-Aguayo C; Lopez-Berestein G; Plowman G; Bagri A; Sood AK; Ellis LM
PLoS One; 2011; 6(10):e23208. PubMed ID: 22028766
[TBL] [Abstract][Full Text] [Related]
15. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
16. The Roles of Neuropilin 2/VEGF-C Axis in a Series of Recurrent Lymphangioma.
Yan X; Zheng N; Xiong X; Duan X; Yang J; Bian H; Zhu Z; Xiong X; Chen X
Eur J Pediatr Surg; 2020 Aug; 30(4):337-342. PubMed ID: 31013538
[TBL] [Abstract][Full Text] [Related]
17. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
Sun P; Gao J; Liu YL; Wei LW; Wu LP; Liu ZY
Mol Cell Biochem; 2008 Jan; 308(1-2):161-8. PubMed ID: 17938864
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
Zhang J; Zhang G; Yang S; Qiao J; Li T; Yang S; Hong Y
World J Surg Oncol; 2016 Feb; 14():51. PubMed ID: 26911617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
